chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started having hip pain where I couldn't put weight on my left leg and the pain went from place to place on my body but it stopped, but the hip pain has been continuous and I'm going to physical therapy. It felt like maybe advance stages of arthritis but I've not had arthritis.
Info has been received from a health professional concerning an 8 year old white female student who on 11/24/98 at 11:17 AM was vaccinated in the left arm with varicella virus vaccine live (lot 625475/0644H). It was noted that she had a diaper rash at the time of vaccination. On 10/31/05, the pt developed vomiting and diarrhea. The symptoms continued and the pt presented to the physician's office on 11/8/05. Additional info has been requested.
Patient received the vaccine on (8/08/2015). Irregular border of swelling near the injection site on the left deltoid muscle (proximal lateral).  The site is approximately 3 inch in diameter and 1/16 inch elevation on 8/12/2015, patient reports that it has worsened today (8/13/2015) and increased to 2 swelling sites connecting each other, each site is approximately 3 inches in diameter on 8/13/2015. It is red, elevated, warm to touch and tender. Patient reports that it hurts when she tries to work using left arm muscle, and it is painful when she sleeps on her side. Patient has tried Ibuprofen and it did not work for the pain. The injection site is on her left arm.
Pt received 2nd dose of moderna vaccine and within 1 minute started presenting symptoms of anxiety, sweat spells, and nausea. Pt was provided with water and a pharmacy bag in case of vomiting. Vomiting did not occur, only slight spit up into the bag. Pt remained conscious the entire time, no syncope occurred. Pt was observed for a time period of 30 minutes; pt felt much better after that time and was released from the pharmacy area.
30 minutes after vaccination mild headache in temple area. 5.5 hours after vaccination sneezing and runny nose and a feeling of dehydration. Following day minor stomach nausea upon waking up but dissipated after an hour. minor pain in right neck muscle.
I am concerned that the vaccine -- Moderna Dose 2 -- was not administered correctly as there was a lot of liquid running down my arm after the injection.  I usually flinch when receiving injections, however, I barely felt the injection.  I am greatly concerned that the dose was not administered leaving me not fully protected after the second dose.
pt exp 3 sz p/vax on 26DEC95;the first sz happened on 29DEC95;the second sz on 30DEC95 & 3rd on 11JAN96;pt doing well @ this time & does not appear to suffer any ill effects from these sz;seen by MD & ped neurologist
ON 1/27/21, DEVELOPED COLD-LIKE SYMPTOMS, TESTED POSITIVE FOR COVID ON 1/27/21.
Mild Fever - Bad Headache - Welts and rash on Chest, Shoulders, Stomach very ictchy
About an hour after receiving the flu shot, the employee experienced itching on the same are as the flu shot was received. She developed redness and swelling below and to the right of where we believe she received the flu shot. A bandaid from the flu shot was removed from the upper deltoid area when symptoms began but warmth, redness and swelling occurred in an area lower than the injection. Hydrocortisone applied to site today.
Starting on the day of the 2nd dose vaccine,  later that evening, I felt very tired and fatigued.  I woke up the next day with a fever of 102.8. Took 2 Tylenol and went up as high as 103.   Arm hurt very bad and full body aches, no appetite and lymph nodes swelling.  These symptoms lasted for 3 days.   A few days later,  my lower left side on back started to hurt.  It felt like diverticulitis to me.  I decided to go to Urgent Care and they took blood work and to follow up the next with a CT scan with contrast which came back normal.   I was to continue to modify my diet and monitor myself.   On 5/18/2021 to 5/20/2021 I had extreme menstraul-like pain with cramps and wanted to report this adverse reaction.  My doctor ordered a pelvic ultrasound which came back normal.
Within 12 hours of the dosage typical symptoms reported such as as body aches, mild fever, chills, headache, injection site soreness were experienced. Following that for 12-48 hours following the vaccine administration, severe burning pain was felt in joints and throughout the body. Red inflamed skin was seen on hands, genital area. Visible twitching of face and arm, and leg muscles were seen. Numbness in left side of face was experienced. Severe weakness and inability to lift objects, weakness leading to difficulty standing and walking, spasm in muscles of back and legs, arms, and hands, stiffness in neck, blurred and shifting vision, flashes of light in vision, Etc.
Information has been received from the registered  nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had been administered dose of GARDASIL on 16-MAY-2013 (lot number: H011350; exp date: 21-FEB-2015) (dose, frequency, route and site of administration were not reported). No adverse event was reported. This is one of the reports from the same source. Additional information is not expected.
Initial information received on 26-Sep-2018 regarding an unsolicited valid non serious case received from a Pharmacist. This case involves a 66 years old female patient who experienced pain in her arm after injection, fever of 102 dedree f, swelling in her right arm and tingling in her right arm, while she received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOVAX 23 for Immunisation on 21-Sep-2018. On 21-Sep-2018, the patient received a 0.5 ml single dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UJ011AG via intramuscular route in the right deltoid. On an unknown date, The patient developed a pain in her arm after injection (pain in extremity) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The patient went to hospital for this event. On an unknown date, The patient developed a fever of 102 degree Fahrenheit (pyrexia)  following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The patient went to hospital for this event. On an unknown date, The patient developed a swelling in her right arm (swelling) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The patient went to hospital for this event. On an unknown date, The patient developed a tingling in her right arm paraesthesia following the administration of INFLUENZA QUADRIVAL A-B VACCINE. The patient went to hospital for this event. Final diagnosis was tingling in her right arm, swelling in her right arm, fever of 102 degree Fahrenheit and pain in her arm after injection. Other lab test not reported. An unknown corrective treatment was received. The patient outcome is reported as Unknown for pain in her arm after injection, as Unknown for fever of 102 dedree f, as Unknown for swelling in her right arm and as Unknown for tingling in her right arm.
Experienced an episode of dizziness/vertigo for about an hour. I was driving when it happened and it was pretty severe. I felt like my head was swimming and I felt like my face was tingling and that I was going to faint or pass out.. I made it home safely but barely. a few hours later it is not as severe but I am still very dizzy.
pt recvd vax & devel macular rash; no resp distress noted; approx 2PM pt returned to clinic rx by MD & EPI;
PHN gave vax pt screamed & held breath until became limp & eyes rolled back in head;PHN shook pt & called her name & pt immed responded by crying;p/conferring w/pt's mom PHN gave MMR;no problems noted p/this x/pt crying
Pt recvd dose of measles vax 31JAN91 & w/in 90 seconds of vax pt collapsed but did not lose consciousness; Pt remained under MD observation for 40 mins & for the next 24 hrs by phone; pt had no recurrence of sx & recovered;
Pt describes itchy red lump, approximately size of a half-dollar. OTC treatment recommended but pt states will wait for it to subside (and not use any tx for adverse event).
shingles; Information has been received regarding a case in litigation from a lawyer concerning a female patient of unknown age.  The patient's concurrent conditions, medical history and concomitant medications were not provided.    In 2010, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) for (lot #, dose, and frequency were not provided).         On an unknown date, subsequently to zoster vaccine live (ZOSTAVAX) vaccination, the patient was treated by a healthcare professional at local healthcare for shingles (herpes zoster). It was reported that as a direct and proximate result of  use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffering ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was not recovered.   The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).
shingles; This spontaneous report has been received from a lawyer regarding a case in litigation, concerning a female patient of unknown age. Her medical history, concurrent conditions and concomitant medications were not reported. On or about 30-OCT-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, lot #, expiration date, dosage, anatomical location and route of administration were not reported), as prescribed and/or administered by a pharmacist at a pharmacy, for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to vaccination, she was treated by a physician for shingles (herpes zoster). As a direct and proximate result of zoster vaccine live (ZOSTAVAX) use, the patient had and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for those injuries; significant medical and related expenses as a result of those injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome for herpes zoster was considered to be not recovered.
First fatigue about 4 hours after vaccination, then body aches and chills, followed by a low fever.  Did not take medication until 14 hours after vaccination, then took tylenol.  Headache also occurred and continues now 48 hours after.
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine taken during pregnancy) in a 36-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (Patient has prior history of alcohol intake 1 glass a week.). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 30-Dec-2020 and the estimated date of delivery was 06-Oct-2021. On 31-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine taken during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourth week of the pregnancy.  On 31-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine taken during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Pregnancy test: positive (Positive) positive. On 09-Mar-2021, Ultrasound scan normal: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information was provided.  The patient gave birth to live full term babies on 27-Feb-2016 and 30-Jun-2018. The patient had no maternal history of subfertility or complications/acute illness. The patient had established prenatal care. The estimated date of conception was reported as 14-Jan-2021 and  number of fetus was reported as 1.
Felt high later in day and into night 2:30am got up to use restroom returning to bed passed out trying to into bed passed out again took things slow next day and stayed in bed and ate very little mon-wed getting better each day thur felt like I was going to pass out again called Dr  and said sound like I was getting better if I pass out go straight to ER It took a good week to get back to normal
Pt felt alteration in breathing, fluttering in chest (known hx of PVCs) Was evaluated/monitored by EMTs at site with return to baseline.
called to report a TE for two different days FEB 9th and FEB 27th and she stated that she did not know if this vaccine had been given to anyone she said that it was possible because the vaccine was not discarded.; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (called to report a TE for two different days FEB 9th and FEB 27th and she stated that she did not know if this vaccine had been given to anyone she said that it was possible because the vaccine was not discarded.) and NO ADVERSE EVENT (no adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (called to report a TE for two different days FEB 9th and FEB 27th and she stated that she did not know if this vaccine had been given to anyone she said that it was possible because the vaccine was not discarded.) and NO ADVERSE EVENT (no adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (called to report a TE for two different days FEB 9th and FEB 27th and she stated that she did not know if this vaccine had been given to anyone she said that it was possible because the vaccine was not discarded.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (called to report a TE for two different days FEB 9th and FEB 27th and she stated that she did not know if this vaccine had been given to anyone she said that it was possible because the vaccine was not discarded.).    Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.
Information has been received from a nurse concerning a female who on an unspecified date, was vaccinated with the first dose of GARDASIL.  The nurse reported that the patient was getting HPV vaccine, and fainted and fell into a full blown seizure.  The patient was monitored at the office, recovered, and was sent home.  Upon internal review, fell into a full blown seizure was determined to be an other important medical event.  No further information is available.
got COVID even though had all shots; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (got COVID even though had all shots) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got COVID even though had all shots). At the time of the report, COVID-19 (got COVID even though had all shots) outcome was unknown. Concomitant drugs were not reported. It was reported that patient had all the shots and then got COVID-19. Treatment medications were not provided.   Reporter did not allow further contact
Multiple nodules found in my lungs and clavicle(s); Multiple nodules found in my lungs and clavicle(s); first dose on 23Jun2021 and second dose on 23Jun2021; This is a spontaneous report from a contactable consumer (patient) reporting for himself. A 33-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0181), via an unspecified route of administration, administered in Right arm on 23Jun2021 15:00 at the age of 33-years-old as dose 1, single and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0177), via an unspecified route of administration, administered in Left arm on 23Jun2021 at the age of 33-years-old as dose 2, single for covid-19 immunisation. Medical history included asthma from an unknown date, known allergies to shellfish from an unknown date. Concomitant medications included vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]) taken for an unspecified indication, vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) taken for an unspecified indication and zinc (ZINC) taken for an unspecified indication from unspecified date received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has been tested for COVID-19 since the vaccination. Device Date: 18Sep2021. On 26Aug2021 at 12:00, the patient experienced Multiple nodules found in his lungs and clavicle(s). Adverse events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for adverse events. The patient underwent lab tests and procedures which included COVID 19 test (sars-cov-2 test) (Nasal Swab): negative on 26Aug2021. The case was reported as non-serious with no seriousness criteria of resulting in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. The outcome of events was unknown.  Follow-Up (21Sep2021): Follow-up attempts are completed. No further information is expected.
This spontaneous case initially received on 02-Nov-2016, was reported by a company representative and concerns an a 4-year-old patient of unknown age and gender. Weight: not provided; Height: not provided. Concomitant medication: not reported. Administration of company suspect drug(s): On an unknown date, the patient received AFLURIA. Dose regimen: Not reported, Route of administration: Not Reported. Batch number: Not reported. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, gave AFLURIA to a 4 year old (outcome: not reported, special circumstances: drug administered to patient of inappropriate age).
Patient began with throat and tongue swelling 20 minutes after vaccination in office. Patient provided Benadryl 50 mg Intramuscular and Solu Medrol 80 mg Intramuscular was discharged home advised if symptoms worsen to use Epi Pen and call EMS for transport to ED.
Standard reaction like a flu; A little fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Standard reaction like a flu), PYREXIA (A little fever) and HEADACHE (Headache) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     The patient's past medical history included Cancer from 2016 to 2017. Concurrent medical conditions included Allergy to antibiotic (sulfites), Allergy to antibiotic (Trimethoprim), Allergy to antibiotic (Ceftriaxone), Neck pain (neck issues, start date: 25 years ago), Arthritis (Start Date: 15 years ago) and Scoliosis (Start Date: since she was born). Concomitant products included IBUPROFEN for Neck pain, ACYCLOVIR [ACICLOVIR] and VITAMINS NOS for an unknown indication.    On 20-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Standard reaction like a flu), PYREXIA (A little fever) and HEADACHE (Headache). On 21-May-2021, INFLUENZA LIKE ILLNESS (Standard reaction like a flu), PYREXIA (A little fever) and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included ibuprofen for headache after 2nd dose.  Patient height was 5'8.  After second shot she got sick, she thought her immune system was wakened, and received antibiotics, then doctors told her she developed an allergic reaction to sulfites, Trimethoprim and Ceftriaxone.   This case was linked to MOD-2022-495173, MOD-2022-495241 (Patient Link).
Nephropathy in lower right foot; red/blotchy area; Looks like "mosquito bite"; Raised area; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Nephropathy in lower right foot), RASH MACULAR (red/blotchy area), RASH PAPULAR (Looks like "mosquito bite") and RASH (Raised area) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0S4C21A and 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jun-2021, the patient experienced HYPOAESTHESIA (Nephropathy in lower right foot), RASH MACULAR (red/blotchy area), RASH PAPULAR (Looks like "mosquito bite") and RASH (Raised area). At the time of the report, HYPOAESTHESIA (Nephropathy in lower right foot), RASH MACULAR (red/blotchy area), RASH PAPULAR (Looks like "mosquito bite") and RASH (Raised area) had not resolved. Not Provided          No concomitant medication were given.  No treatment details were provided